Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial

[1]  A. Efron,et al.  Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. , 2013, The Lancet. Infectious diseases.

[2]  Y. Manabe,et al.  Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda. , 2013, The International Journal of Tuberculosis and Lung Disease.

[3]  S. Swaminathan,et al.  Efficacy of a Six-Month versus a 36-Month Regimen for Prevention of Tuberculosis in HIV-Infected Persons in India: A Randomized Clinical Trial , 2012, PloS one.

[4]  G. Maartens,et al.  Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  R. Chaisson,et al.  Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis , 2012, PLoS medicine.

[6]  S. Lawn,et al.  Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community , 2012, PloS one.

[7]  R. Chaisson,et al.  New regimens to prevent tuberculosis in adults with HIV infection. , 2011, The New England journal of medicine.

[8]  M. Pai,et al.  Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms , 2011, European Respiratory Journal.

[9]  K. Castro,et al.  6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial , 2011, The Lancet.

[10]  M. Egger,et al.  Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[11]  Madhukar Pai,et al.  Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review , 2011, Thorax.

[12]  S. Lawn,et al.  Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy , 2010, AIDS.

[13]  N. Ford,et al.  Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa , 2010, AIDS.

[14]  J. Kaldor,et al.  Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. , 2009, The Journal of infectious diseases.

[15]  R. Chaisson,et al.  Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort , 2009, AIDS.

[16]  D. Moher,et al.  Improving the reporting of pragmatic trials: an extension of the CONSORT statement , 2008, BMJ : British Medical Journal.

[17]  L. Myer,et al.  Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Richard D Moore,et al.  The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil , 2007, AIDS.

[19]  M. Pai,et al.  Serial Testing for Tuberculosis: Can We Make Sense of T Cell Assay Conversions and Reversions? , 2007, PLoS medicine.

[20]  G. Maartens,et al.  Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection. , 2007, American journal of respiratory and critical care medicine.

[21]  L. Myer,et al.  Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control , 2006, AIDS.

[22]  R. Wilkinson,et al.  Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. , 2006, The Journal of infectious diseases.

[23]  C. Horsburgh,et al.  Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy. , 2003, AIDS.

[24]  John L. Johnson,et al.  Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults , 2001, AIDS.

[25]  D. Fuchs,et al.  Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults , 2001, AIDS.

[26]  M. Narita,et al.  Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. , 1998, American journal of respiratory and critical care medicine.

[27]  J M Lachin,et al.  Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. , 1986, Biometrics.

[28]  E. L. Crossley.  A GENERAL REVIEW , 1954 .

[29]  A. Efron,et al.  Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. , 2013, The Lancet. Infectious diseases.

[30]  Gundo Weiler,et al.  Global Update on HIV Treatment 2013: Results, Impact and Opportunities , 2013 .

[31]  J. Volmink,et al.  Treatment of latent tuberculosis infection in HIV infected persons. , 2004, The Cochrane database of systematic reviews.

[32]  P. Neuvonen,et al.  Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes , 2001, European Journal of Clinical Pharmacology.

[33]  K K Lan,et al.  A comparison of sample size methods for the logrank statistic. , 1992, Statistics in medicine.

[34]  S. Ferebee.  Controlled chemoprophylaxis trials in tuberculosis. A general review. , 1970, Bibliotheca tuberculosea.

[35]  Ferebee Sh.  Controlled chemoprophylaxis trials in tuberculosis. A general review. , 1970 .